Colgate-Palmolive
1,765 hedge funds and large institutions have $60.7B invested in Colgate-Palmolive in 2024 Q1 according to their latest regulatory filings, with 155 funds opening new positions, 565 increasing their positions, 717 reducing their positions, and 107 closing their positions.
180% more call options, than puts
Call options by funds: $1.15B | Put options by funds: $410M
45% more first-time investments, than exits
New positions opened: 155 | Existing positions closed: 107
11% more capital invested
Capital invested by funds: $54.9B → $60.7B (+$5.85B)
1% more funds holding
Funds holding: 1,740 → 1,765 (+25)
1.49% less ownership
Funds ownership: 83.55% → 82.06% (-1.5%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
21% less repeat investments, than reductions
Existing positions increased: 565 | Existing positions reduced: 717
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$757M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$335M |
| 3 |
BlackRock
New York
|
+$281M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$147M |
| 5 |
MAM
Magellan Asset Management
Sydney,
Australia
|
+$122M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.74B |
| 2 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$365M |
| 3 |
Millennium Management
New York
|
-$271M |
| 4 |
Swedbank
Stockholm,
Sweden
|
-$246M |
| 5 |
Two Sigma Advisers
New York
|
-$205M |
CL Hedge Fund Activity: Q1 2024 in Review
1,765 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q1 2024, worth a combined $60.7B — up 11% from $54.9B a quarter earlier.
Buyers outnumbered sellers: 155 funds opened new CL positions and 107 closed out — a net gain of 48 holders — while 565 added to existing stakes and 717 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $757M. The largest seller was Morgan Stanley, cutting an estimated $1.74B.
- 1,765 institutional investors held Colgate-Palmolive (CL) as of Q1 2024, up from 1,740 in Q4 2023.
- Funds reported $60.7B of Colgate-Palmolive stock for Q1 2024, up 11% quarter-over-quarter.
- 155 funds opened new Colgate-Palmolive positions in Q1 2024 and 107 closed out, a net change of +48 holders.
- The largest Colgate-Palmolive buyer in Q1 2024 was T. Rowe Price Associates, an estimated $757M added.
- The largest Colgate-Palmolive seller in Q1 2024 was Morgan Stanley, an estimated $1.74B sold.
Based on aggregated 13F filings for Q1 2024.